Cite Filings / FDMT / 0000093751-26-000197

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

4D Molecular Therapeutics, Inc. Filed 2026-05-12 Acc 0000093751-26-000197

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-10 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-13 EFFECT Notice of Effectiveness
2026-05-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-11 CORRESP Correspondence Between Filers and SEC Staff
2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…